Carcinogen News and Research

RSS

Thalidomide - new treatment for cancer

Thalidomide, famous in the 60's because of limb deformities in babies born to women who had taken it for morning sickness, was withdrawn in 1961. Now doctors say it could be used as a treatment for cancer.

8 Mar 2005

An apple a day keeps breast cancer away

An apple a day can help keep breast cancer away, according to a study in rats by food scientists at Cornell University.

1 Mar 2005

Eleventh Edition of the Report on Carcinogens

The Department of Health and Human Services released its Eleventh Edition of the Report on Carcinogens today, adding seventeen substances to the growing list of cancer-causing agents, bringing the total to 246.

31 Jan 2005

Tobacco industry involvement in p53 gene research impairs integrity of the scientific process

The strategies used by the tobacco industry to counteract research linking tobacco smoke to cancer-causing mutations in a gene called p53 are detailed in a study published in The Lancet.

13 Jan 2005

Zinc treatment may help prevent esophageal and oral cancers

Cancer researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found that zinc treatment may help prevent esophageal and oral cancers in those individuals at high risk.

9 Jan 2005

Novel mutagenesis screen used to identify genetic suppressors of thrombosis

Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.

6 Dec 2004

Study finds that stomach cancer originates from bone marrow derived stem cells, rather than from stomach stem cells

A common assumption among cancer specialists is that most cancers originate from tissue stem cells – for example, the gastric stem cells contained in the lining of the stomach.

29 Nov 2004

Cotinine not linked to hearing loss

Levels of cotinine, a chemical that is made by the body from nicotine, which is found in cigarette smoke, does not appear to be linked to hearing loss, according to an article in the November issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Nov 2004

New way to study individual living bacteria cells and analyze their chemistry

Researchers at the U.S. Department of Energy's Argonne National Laboratory have found a new way to study individual living bacteria cells and analyze their chemistry.

22 Oct 2004

Study will evaluate arsenic exposure from the environment and its potential carcinogenic effects

The National Cancer Institute has awarded the Arizona Cancer Center at the University of Arizona Health Sciences Center a three-year grant to evaluate associations between elevated arsenic exposure and cancer incidence in Arizona and Mexico.

19 Oct 2004

A misconception that eating wasabi decongests the nose

Wasabi, (Wasabia japonica) is commonly known as the Japanese horseradish used to enhance the enjoyment of sushi.

18 Sep 2004

Slimming agents could pose major health risk

Commonly used nutritional supplements and body-building agents for elite athletes could pose an increased risk of cancer according to a study undertaken at the University of Sydney.

16 Sep 2004

Growing up in polluted towns and cities increases risk of lung health issues

Children who grow up in towns and cities with high pollution levels are at increased risk of lung health issues or low functioning lungs. New research suggests that pollutants from vehicle emissions and fossil fuels have an adverse effect on a child's lung development and can also lower childrens lifetime breathing capacity.

8 Sep 2004

Blueberries may lower cholesterol

New research from the U.S. Department of Agriculture shows that blueberries may lower cholesterol as effectively as a commercial drug and have the potential for fewer adverse side effects.

23 Aug 2004

First evidence of the molecular link between inflammation and cancer

The investigators found that a gene called I-kappa-B kinase (IKK beta), a pro-inflammatory gene, acts differently in two cell types to cause cancer. When IKK beta was deleted, the cancer incidence and tumor growth in mice was decreased by nearly 80 percent.

5 Aug 2004